Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PU.1 is a mediator of the reactive stromal response associated with castration-resistant prostate cancer.

Communications biology·2026
Same author

Re: Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials.

European urology·2026
Same author

Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.

European urology oncology·2026
Same author

Pathological assessment of morcellated tissue after ERBT: insights from a two-round Delphi survey.

World journal of urology·2026
Same author

Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Nature reviews. Urology·2026
Same author

Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy.

Clinical and translational medicine·2026
Same journal

Algorithm-hardware co-design of neuromorphic networks with dual memory pathways.

Nature machine intelligence·2026
Same journal

Plagiarism in the Age of Generative Artificial Intelligence: The advent of generative artificial intelligence (GenAI) tools is challenging the scientific community's understanding of the meaning and significance of plagiarism. A new definition of research misconduct is needed that specifically addresses the use of GenAI writing tools.

Nature machine intelligence·2026
Same journal

Platonic representation of foundation machine learning interatomic potentials.

Nature machine intelligence·2026
Same journal

Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation.

Nature machine intelligence·2026
Same journal

A generative artificial intelligence approach for peptide antibiotic optimization.

Nature machine intelligence·2026
Same journal

LLMs displaying less cognitive bias are not necessarily better decision makers.

Nature machine intelligence·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2025

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

3.6K

Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling.

Pushpak Pati1, Sofia Karkampouna2,3, Francesco Bonollo2

  • 1IBM Research Europe, Rüschlikon, Switzerland.

Nature Machine Intelligence
|September 23, 2024
PubMed
Summary
This summary is machine-generated.

VirtualMultiplexer uses AI to create multiplexed immunohistochemistry images from H&E stains, improving cancer research. This AI tool accelerates histopathology workflows and cancer biology studies.

Keywords:
Cancer imagingMachine learning

More Related Videos

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.1K
Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

20.5K

Related Experiment Videos

Last Updated: Jun 12, 2025

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

3.6K
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.1K
Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

20.5K

Area of Science:

  • Computational biology
  • Digital pathology
  • Artificial intelligence in medicine

Background:

  • Tumor spatial heterogeneity is crucial for cancer initiation and progression.
  • Current histopathology relies on time-consuming, tissue-intensive serial staining, leading to misaligned images.
  • There's a need for efficient methods to analyze multiple protein markers simultaneously.

Purpose of the Study:

  • To introduce VirtualMultiplexer, an AI toolkit for synthesizing multiplexed immunohistochemistry (mIHC) images from single H&E images.
  • To demonstrate the toolkit's ability to capture biologically relevant staining patterns without serial sections or registration.
  • To validate the clinical utility of AI-generated mIHC data in predicting cancer endpoints.

Main Methods:

  • Developed VirtualMultiplexer, a generative AI model, to synthesize mIHC images for markers (AR, NKX3.1, CD44, CD146, p53, ERG) from H&E images.
  • Assessed image quality qualitatively and quantitatively, comparing generated images to real mIHC.
  • Validated model transferability across tissue scales and patient cohorts without fine-tuning.
  • Trained a graph transformer model on synthesized mIHC data for clinical endpoint prediction.

Main Results:

  • VirtualMultiplexer rapidly generates high-quality, robust, and precise virtual mIHC datasets indistinguishable from real ones.
  • The AI model successfully transfers across different tissue scales and patient cohorts without retraining.
  • AI-generated mIHC data significantly improved clinical prediction accuracy in downstream tasks across multiple cancer types.
  • Multiplexed learning using spatial protein distribution enhanced predictive performance.

Conclusions:

  • VirtualMultiplexer offers a powerful AI-driven solution to accelerate histopathology workflows and cancer biology research.
  • AI-assisted multiplexed tumor imaging provides high-quality data for robust analysis and clinical prediction.
  • This approach overcomes limitations of traditional methods, enabling deeper insights into tumor heterogeneity and progression.